Skip to search formSkip to main contentSkip to account menu

acetylacetoin reductase (NADH)

Known as: AACR II 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Long Noncoding RNA and Cancer: A New Paradigm.
In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in… 
Review
2017
Review
2017
Breast Cancer Immunotherapy: Facts and Hopes
  • L. Emens
  • Clinical Cancer Research
  • 2017
  • Corpus ID: 20996173
Immunotherapy is revolutionizing the management of multiple solid tumors, and early data have revealed the clinical activity of… 
Highly Cited
2016
Highly Cited
2016
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
Purpose: Approximately one-third of patients with non–small cell lung cancer (NSCLC) harboring tumors with EGFR-tyrosine kinase… 
Highly Cited
2016
Highly Cited
2016
Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
Hypoxia is a common feature of solid tumors and is associated with aggressiveness and poor patient outcomes. Exosomes, initially… 
Review
2016
Review
2016
DNA Methylation in Cancer and Aging.
DNA methylation is known to be abnormal in all forms of cancer, but it is not really understood how this occurs and what is its… 
Highly Cited
2016
Highly Cited
2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.
Small-molecule inhibitors of the CDK4/6 cell-cycle kinases have shown clinical efficacy in estrogen receptor (ER)-positive… 
Highly Cited
2016
Highly Cited
2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome following ipilimumab treatment in… 
Highly Cited
2016
Highly Cited
2016
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial carcinoma are based on clinicopathologic… 
Highly Cited
2016
Highly Cited
2016
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
Purpose: An anti-HER2 antibody–drug conjugate with a novel topoisomerase I inhibitor, DS-8201a, was generated as a new antitumor… 
Review
2015
Review
2015
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
UNLABELLED The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)